| Literature DB >> 28426753 |
Daniel K Fowler, Scott Stewart, Steve Seredick, Judith S Eisen, Kryn Stankunas, Philip Washbourne.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0159277.].Entities:
Year: 2017 PMID: 28426753 PMCID: PMC5398664 DOI: 10.1371/journal.pone.0176543
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Overview of three-fragment MultiSite Gateway cloning and novel lentiviral destination vectors.
(A) Schematic of an LR recombination reaction and the resulting vector. Site-specific recombination events (red lines) between attR and attL sites from a 5’, middle, and 3’ entry vector with a destination vector replaces the ccdB/CmR selection cassette of the destination vector with the mobile DNA elements from the entry vectors, leaving destination vector-specific 5’ and 3’ sequences intact. (B) Schematic of lentiviral destination vectors pEpic and pEpic_Lite. attR3 and 4 sites flanking the ccdB/CmR selection cassette are positioned in an anti-sense orientation to viral RNA expression driven by a Rous sarcoma virus (RSV) promoter. pEpic_Lite lacks puromycin resistance (PuroR). LTR = long terminal repeat; RRE = Rev response element; cPPT = central polypurine tract; ccdB = E. coli ccdB toxin; CmR = chloramphenicol resistance; mPGK = mouse phosphoglycerate kinase promoter; WPRE = woodchuck hepatitis virus posttranslational regulatory element.